Clinical Laboratory Improvement Amendments of 1988
This article was originally published in The Gray Sheet
Executive SummaryThe Health Care Financing Administration imposes sanctions against two laboratories, taking enforcement action for the first time under CLIA '88. HCFA suspended Medicare payments to Pioneer Medical Laboratories of Jersey City, New Jersey and Stroink Pathology Laboratories of Bloomington, Illinois, effective Feb. 1. In a March 31 press release, HHS says that Pioneer had been found to be "reporting fictitious patient test results," and "fabricating quality control records." HCFA suspended the firm's CLIA certificate. Stroink, which had deficiencies in its diagnostic pap smear testing, had its license limited to exclude cytology testing.
You may also be interested in...
The Trump administration does not believe its partnership with industry on therapeutics for COVID-19 should include conditions on pricing, US Health Secretary Alex Azar tells Congress.